COMMUNICATION:
Rho-associated Kinase Directly Induces Smooth Muscle Contraction through Myosin Light Chain Phosphorylation*

(Received for publication, March 4, 1997)

Yasuko Kureishi , Sei Kobayashi Dagger , Mutsuki Amano , Kazushi Kimura , Hideo Kanaide §, Takeshi Nakano , Kozo Kaibuchi and Masaaki Ito par

From the First Department of Internal Medicine, Mie University School of Medicine, Tsu, Mie 514, Japan, the Dagger  First Department of Physiology, Yamaguchi University School of Medicine, Ube, Yamaguchi 755, Japan, the  Division of Signal Transduction, Nara Institute of Science and Technology, Ikoma, Nara 630-01, Japan, and the § Division of Molecular Cardiology, Research Institute of Angiocardiology, Faculty of Medicine, Kyushu University, Fukuoka 812, Japan

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES


ABSTRACT

Small GTPase Rho plays pivotal roles in the Ca2+ sensitization of smooth muscle. However, the GTP-bound active form of Rho failed to exert Ca2+-sensitizing effects in extensively Triton X-100-permeabilized smooth muscle preparations, due to the loss of the important diffusible cofactor (Gong, M. C., Iizuka, K., Nixon, G., Browne, J. P., Hall, A., Eccleston, J. F., Sugai, M., Kobayashi, S., Somlyo, A. V., and Somlyo, A. P. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 1340-1345). Here we demonstrate the contractile effects of Rho-associated kinase (Rho-kinase), recently identified as a putative target of Rho, on the Triton X-100-permeabilized smooth muscle of rabbit portal vein. Introduction of the constitutively active form of Rho-kinase into the cytosol of Triton X-100-permeabilized smooth muscle provoked a contraction and a proportional increase in levels of monophosphorylation of myosin light chain in both the presence and the absence of cytosolic Ca2+. These effects of constitutively active Rho-kinase were wortmannin (a potent myosin light chain kinase inhibitor)-insensitive. Immunoblot analysis revealed that the amount of native Rho-kinase was markedly lower in Triton X-100-permeabilized tissue than in intact tissue. Our results demonstrate that Rho-kinase directly modulates smooth muscle contraction through myosin light chain phosphorylation, independently of the Ca2+-calmodulin-dependent myosin light chain kinase pathway.


INTRODUCTION

Smooth muscle contraction is primarily regulated by the levels of phosphorylation of myosin light chain (MLC),1 which has heretofore been considered to be governed by a Ca2+-calmodulin (CaM)-dependent MLC kinase pathway (1-4). However, as the use of Ca2+ indicator revealed that the force/Ca2+ ratio is variable, the Ca2+-CaM-dependent MLC kinase pathway cannot solely account for the mechanisms of agonist- or GTPgamma S-induced increases in the force/Ca2+ ratio, so-called Ca2+ sensitization (1, 5-9). Thus, an additional mechanism that can regulate Ca2+ sensitization of smooth muscle has been proposed. Using membrane permeabilization of smooth muscle, the possibility that monomeric Ras family G-proteins, such as Rho, contribute to Ca2+ sensitization of smooth muscle was demonstrated (10-12). Direct activation of G-proteins by the application of GTPgamma S (8, 9), agonists (1, 5-8), and GTP-activated Rho (10-12) could exert Ca2+-sensitizing effects on saponin- or beta -escin-permeabilized smooth muscle. However, the activated Rho failed to induce Ca2+ sensitization of extensively Triton X-100-permeabilized smooth muscle (11). Considering that extensive Triton X-100-permeabilization allows higher molecular weight compounds to diffuse from the cytosol of smooth muscle of the rabbit portal vein (13), important diffusible factor(s) for the Ca2+ sensitization of smooth muscle might be lost during extensive permeabilization by Triton X-100, an event that would result in no response to activated Rho.

We have recently reported that Rho-kinase, which is activated by GTP-bound active form of Rho (14-16), phosphorylates not only MLC, thereby activating myosin ATPase (17), but also myosin phosphatase, thus inactivating it in vitro (18). These findings in a cell-free system, plus the previous reports of G-protein-mediating Ca2+ sensitization as described above, suggest that Rho-kinase may induce contraction and concomitant MLC phosphorylation of the smooth muscle. We examined the effects of the constitutively active form of Rho-kinase on smooth muscle extensively permeabilized by Triton X-100 and attempted to determine if Rho-kinase would be the factor lost during extensive Triton X-100 permeabilization.


EXPERIMENTAL PROCEDURES

Materials and Chemicals

The catalytic subunit of recombinant Rho-kinase (CAT; molecular mass is about 80 kDa) was expressed as a glutathione S-transferase fusion protein and purified using a baculovirus system and a glutathione-Sepharose column (17). The kinase activity of the elute was determined by phosphorylation assay using S6 peptide as a substrate (15) in buffer containing 50 mM Tris-HCl, pH 7.5, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, and 100 µM ATP (0.5-20 Gbq/mmol). CaM was purified from bovine brain by previously described method (19). Other materials and chemicals were obtained from commercial sources.

Force Measurement of the Triton X-100-permeabilized Smooth Muscle of the Rabbit Portal Vein

Small strips of male rabbit (2-2.5 kg) portal veins were manually dissected (50-100 µm wide and 0.5-1 mm long), connected to an isometric force transducer (UL-2GR, Minebea, Japan), and mounted in a well (200 µl) on a bubble plate (6). After recording contractions evoked by 118 mM K+, the strips were incubated in relaxing solution, followed by 0.5% Triton X-100 for 20 min at 25 °C. The solutions have been described in detail elsewhere (6). CaM (0.5 µM) was added to all reactive solutions for experiments with chemical permeabilization.

Immunoblot Analysis of Rho-kinase and MLC

0.5% Triton X-100-permeabilized and intact rabbit portal veins were homogenized in extraction buffer containing 50 mM Tris-HCl, pH 7.2, 400 mM NaCl, 2 mM EGTA, 1 mM EDTA, 1 mM DTT, 0.1 µM p-amidinophenylmethanesulfonyl fluoride hydrochloride, 10 µg/ml leupeptin, and 1 mM benzamidine. Each extract was centrifuged at 100,000 × g for 30 min at 4 °C, and the supernatant was subjected to SDS-polyacrylamide gel electrophoresis (20) followed by immunoblotting (21). Anti-Rho-kinase rabbit polyclonal antibodies were generated against the glutathione S-transferase fusion-catalytic domain of Rho-kinase (15), and anti-MLC rabbit polyclonal antibodies were provided by Dr. J. T. Stull (University of Texas Southwestern Medical Center, Dallas, TX). Immunostained proteins were visualized by Supersignal (Pierce). Densities of bands of immunostained proteins were quantitated using a scanning densitometer, Densitograph (Atto, Tokyo, Japan).

Measurement of the Extent of MLC Phosphorylation

After treatment with 5.1 µg/ml (0.06 µM) CAT and/or 10 µM wortmannin, the fringe-like strips of the rabbit portal veins permeabilized by Triton X-100 were quickly placed in a frozen slurry of acetone containing 10% trichloroacetic acid and 10 mM DTT to terminate the contractile responses. After depletion of trichloroacetic acid, the strips were homogenized in urea sample buffer containing 20 mM Tris base, 22 mM glycine, pH 8.6, 8 M urea, 10 mM DTT, 10% sucrose, and 0.1% bromphenol blue. The extracts were subjected to glycerol-urea polyacrylamide gel electrophoresis following immunoblotting using anti-MLC antibodies as documented (22). Immunostained proteins were visualized colorimetrically with 4-chloro-1-naphthol and subjected to densitometrical quantitation.


RESULTS AND DISCUSSION

Introduction of CAT, which is not only the constitutively active form of Rho-kinase but also the highly homologous domain among rat (14), bovine (15), human (16), and mouse Rho-associated kinases (23), into the cytosol of the extensively Triton X-100-permeabilized rabbit portal vein smooth muscle provoked a contraction both at a constant cytosolic Ca2+ (pCa 6.5; Fig. 1a) and at a nominally zero cytosolic Ca2+ buffered with 10 mM EGTA (pCa <<  8.0; Fig. 1c). CAT exerted contraction, whereas the vehicle had no effect on the force (Fig. 1, a and c). These contractions were completely reversed by wash out of CAT, contrary to those induced by 10 µM microcystin-LR (24, 25) (Fig. 1b). In the absence of cytosolic Ca2+ at pCa <<  8.0, the CAT-induced contraction was also reversible (data not shown). In neither intact nor alpha -toxin-permeabilized strips of the portal vein did CAT exert the contractile effects (data not shown). These observations are interpreted to mean that constitutively active CAT could be introduced into the cytosol of the smooth muscle only by extensive membrane permeabilization to induce a reversible contraction.


Fig. 1. Representative recordings of the CAT-induced-contraction in 0.5% Triton X-100-permeabilized rabbit portal vein. a, at pCa 6.5, 2.2 µg/ml (0.03 µM) CAT was exogenously loaded. b, at pCa 6.5, 4.4 µg/ml (0.06 µM) CAT-induced contraction was completely reversed by wash out of CAT. c, at pCa <<  8.0, 13.2 µg/ml (0.15 µM). The specific activity of CAT was 41 mol/min/mol enzyme. The elution buffer of a glutathione-Sepharose column (containing 50 mM Tris-HCl, pH 7.5, 2 mM EGTA, 1 mM DTT, 10 mM glutathione) was used as the vehicle. Dose of the vehicle was expressed as a percentage of the total chamber volume (200 µl). These results are representative of three to five independent experiments.
[View Larger Version of this Image (16K GIF file)]

MLC phosphorylation mediated by Ca2+-CaM-dependent MLC kinase pathway plays a primary role in smooth muscle contraction through myosin-actin-interaction and the consequent activation of myosin ATPase (2-4). To investigate involvement of Ca2+-CaM-dependent MLC kinase pathway in the CAT-induced contraction, we examined the effects of wortmannin (WM), a potent MLC kinase inhibitor (26) on force development induced by cumulative application of CAT (Fig. 2). In the presence of cytosolic Ca2+ at pCa 6.5, in which Ca2+-CaM-dependent MLC kinase should be active, 10 µM WM shifted the dose-response curve down and to the right. In the absence of cytosolic Ca2+ at pCa <<  8.0, in which MLC kinase would be hardly activated, 10 µM WM did not affect CAT-induced force development. In the absence of CAT, treatment of 10 µM WM completely inhibited the cytosolic Ca2+-provoked contraction at pCa 6.5, in the Triton X-100-permeabilized fibers. Considering our finding that WM did not affect the activity of CAT up to 100 µM in vitro (data not shown), this WM-sensitive component of CAT-induced contraction at pCa 6.5 seemed to be due to inhibition of the Ca2+-provoked contraction through the Ca2+-CaM-dependent MLC kinase pathway but not related to the CAT-mediated pathway. All these observations suggest that the CAT-induced contraction of smooth muscle of rabbit portal vein permeabilized by Triton X-100 is modulated independently by the Ca2+-CaM-dependent MLC kinase pathway.


Fig. 2. Effect of 10 µM WM on the dose-response curve of CAT. open circle , at pCa 6.5 without WM; triangle , at pCa <<  8.0 without WM; bullet ,; at pCa 6.5 with WM; black-triangle, at pCa <<  8.0 with WM. Abscissa, the molar concentrations (µM) of CAT. Values are the means ± S.E. of five to eight experiments. **, p < 0.01 by ANOVA; N.S., not significant.
[View Larger Version of this Image (17K GIF file)]

To clarify whether CAT induces contraction with a concomitant increase in levels of MLC phosphorylation, we examined the effects of CAT on MLC phosphorylation, using immunoblotting with anti-MLC polyclonal antibody (Fig. 3). As shown in lanes 1-3 of Fig. 3a, at pCa <<  8.0, monophosphorylation of MLC was detected only in the presence of CAT and was insensitive to 10 µM WM (42.77 ± 9.22% of the total amount of immunostained MLC (n = 4) in the absence of WM, 35.95 ± 3.39% (n = 4; p > 0.05) in the presence of WM, respectively). At pCa 6.5, shown in lanes 4-6 of Fig. 3a, CAT potentiated the level of monophosphorylation of MLC (60.33 ± 1.42%, n = 4), which was partially inhibited by 10 µM WM (26.05 ± 5.18%, n = 4, p < 0.01). Based on the statistical analysis and the results in Fig. 2, this WM-sensitive component of CAT-induced MLC phosphorylation at pCa 6.5 also seemed to be due to inhibition of Ca2+-CaM-dependent MLC kinase activity. These results are consistent with that of counterparts of the effects of CAT on the contractile responses (Fig. 3b). It was concluded that CAT potentiates the contractile response by increasing the extent of monophosphorylation of MLC.


Fig. 3. CAT increased the levels of the monophosphorylation of MLC. a, nonphosphorylated (MLC-P0) and monophosphorylated (MLC-P1) forms of the 20-kDa MLCs. Lanes 1 and 4, control; lanes 2 and 5, in the presence of 5.1 µg/ml (0.06 µM) CAT; lanes 3 and 6, in the presence of both 5.1 µg/ml (0.06 µM) CAT and 10 µM WM; lanes 1-3, at pCa <<  8.0; lanes 4-6, at pCa 6.5. The specific activity of CAT was 23 mol/min/mol enzyme. These results are representative of four independent experiments. b, quantitation and comparison of effects of CAT on the extent of MLC monophosphorylation (white bar) with the contractile responses (hatched bar). Data are the means ± S.E. of four experiments. Densitometrical quantitation was standardized as the percentage of the total amount of immunostained MLC. Contractile responses were standardized as the percentage of maximal Ca2+-induced contraction at pCa 4.5. The numbers below each column are identical with those for the lanes in a.
[View Larger Version of this Image (29K GIF file)]

To determine if native Rho-kinase is one of the cofactors diffusible during permeabilization by Triton X-100, we examined the amounts of native Rho-kinase in intact and permeabilized fibers by immunoblot analysis using rabbit polyclonal antibodies against Rho-kinase. To standardize the densitometrical value, the ratio of densitometrical quantification of immunostaining of Rho-kinase to that of MLC was calculated in both intact and permeabilized fibers. As shown in Fig. 4, the amounts of native Rho-kinase in the Triton X-100-permeabilized rabbit portal vein were markedly lower than those in intact tissue (0.06 ± 0.01 (n = 4) for permeabilized sample, 0.95 ± 0.02 (n = 4) for intact sample, respectively), whereas the amounts of the possible cytoskeletal proteins, such as MLC and myosin heavy chain in permeabilized fibers were similar to the counterparts of intact fibers. These results confirm that extensive permeabilization by Triton X-100 allows for the loss of cytosolic proteins, including Rho-kinase, whereas cytoskeletal proteins such as myosin are stable. Based on all of these findings taken together plus evidence that the direct activation of G-proteins did not exert contractile effects on the extensively Triton X-100-permeabilized smooth muscle (11), we consider that Rho-kinase may be a valid candidate for the key molecule in G-protein-mediating smooth muscle contraction and may be the molecule lost during extensive permeabilization by Triton X-100.


Fig. 4. Comparison of the amount of Rho-kinase in intact fibers with that in permeabilized fibers. a, lanes A, immunoblotting of Rho-kinase; lanes B, immunoblotting of MLC; lanes C, Coomassie Brilliant Blue staining. Lanes 1, 3, and 5, intact fibers. Lanes 2, 4, and 6, permeabilized fibers. The aliquots in lanes A and C were resolved by 5% SDS-polyacrylamide gels, and those in lane B were resolved by 15% SDS-polyacrylamide gels, respectively. Doublet with a molecular mass about 200 kDa in lanes 5 and 6 are myosin heavy chains. These results shown are representative of three independent experiments. b, densitometrical analysis of the results shown in a. Data represent the ratio of densitometrical quantification of immunostaining of Rho-kinase to that of MLC in both intact and permeabilized fibers. The values represent the means ± S.E. of three experiments standardized as the relative ratio to MLC.
[View Larger Version of this Image (18K GIF file)]

We demonstrate here what seems to be the first evidence that Rho-kinase is a direct effector on the contractile apparatus of smooth muscle, independently of the Ca2+-CaM-dependent MLC kinase pathway. Except for Ca2+-independent MLC kinase (9, 13), we find no documentation that the exogenous addition of kinases to the cytosol of permeabilized smooth muscle directly exerts contractile responses comparable with findings with CAT. Because the inhibition of myosin phosphatase may possibly be the main mechanism of the G-protein-mediating Ca2+ sensitization of smooth muscle contraction (1, 9, 24, 25, 27), the CAT-induced contraction of G-protein-uncoupled smooth muscle permeabilized by Triton X-100 (Fig. 1) may be also mediated by the inhibition of myosin phosphatase. This notion is supported by our previous finding that Rho-kinase inhibited the activity of myosin phosphatase through thiophosphorylation of its myosin-binding subunit in vitro (18). However, at cytosolic zero Ca2+, microcystin-LR-induced contraction of the permeabilized smooth muscle was reduced by an MLC kinase inhibitor (25), whereas the CAT-induced contraction was insensitive to it (Fig. 2). Such differential sensitivities of the MLC kinase inhibitor to CAT- and myosin phosphatase inhibitior-induced contractions support the idea that myosin phosphatase inhibition alone cannot account for the CAT-induced contraction at the cytosolic zero Ca2+. Taking this together with our report that Rho-kinase directly provokes the phosphorylation of MLC and activates myosin in vitro (17), we suggest that the mechanism(s) of CAT-induced contraction of Triton X-100-permeabilized rabbit portal vein might be a concomitant monophosphorylation of MLC directly induced by CAT independently of a Ca2+-CaM-dependent MLC kinase pathway. We propose that Rho-kinase is considered a valid key molecule in G-protein-mediating Ca2+ sensitization of smooth muscle contraction.


FOOTNOTES

*   This work was supported in part by grants-in-aid for Scientific Research and for Cancer Research, by a grant for Research and Education in Yamaguchi University from the Ministry of Education, Science, Sports, and Culture, Japan, and by grants from the Naito Foundation, the Research Project on Cerebral Vasospasm from Mie University School of Medicine, and the Mie Medical Research Foundation.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
par    To whom correspondence should be addressed. Tel.: 81-59-231-5015; Fax: 81-59-231-5201; E-mail: m-ito{at}clin.medic.mie-u.ac.jp.
1   The abbreviations used are: MLC, myosin light chain; GTPgamma S, guanosine 5'-[gamma -thio]triphosphate; Rho-kinase, Rho-associated serine/threonine kinase; CaM, calmodulin; CAT, the catalytic subunit of recombinant Rho-kinase; WM, wortmannin; DTT, dithiothreitol.

ACKNOWLEDGEMENTS

We thank Dr. J. T. Stull for providing the anti-myosin antibody, Drs. D. J. Hartshorne and M. P. Walsh for helpful discussions, and M. Ohara for critical comments on the manuscript.


REFERENCES

  1. Somlyo, A. P., and Somlyo, A. V. (1994) Nature 372, 231-236 [CrossRef][Medline] [Order article via Infotrieve]
  2. Kamm, K. E., and Stull, J. T. (1985) Annu. Rev. Pharmacol. Toxicol. 25, 593-603 [CrossRef][Medline] [Order article via Infotrieve]
  3. Hartshorne, D. J. (1987) in Physiology of the Gastrointestinal Tract (Johnson, D. R., ed), Vol. 1, pp. 423-482, Raven Press, New York
  4. Sellers, J. R., and Adelstein, R. S. (1987) in The Enzyme (Boyer, P., and Krebs, E. G., eds), Vol. 18, pp. 381-418, Academic Press, San Diego, CA
  5. Bradley, A. B., and Morgan, K. G. (1987) J. Physiol. (London) 385, 437-448 [Abstract]
  6. Kobayashi, S., Kitazawa, T., Somlyo, A. V., and Somlyo, A. P. (1989) J. Biol. Chem. 264, 17997-18004 [Abstract/Free Full Text]
  7. Himpens, B., Kitazawa, T., and Somlyo, A. P. (1990) Pflügers Arch. Gen. Physiol. 417, 21-28
  8. Kitazawa, T., Kobayashi, S., Horiuchi, K., Somlyo, A. V., and Somlyo, A. P. (1989) J. Biol. Chem. 264, 5339-5342 [Abstract/Free Full Text]
  9. Kubota, Y., Nomura, M., Kamm, K. E., Mumby, M. C., and Stull, J. T. (1992) Am. J. Physiol. 262, C405-C410 [Abstract/Free Full Text]
  10. Hirata, K., Kikuchi, A., Sasaki, T., Kuroda, S., Kaibuchi, K., Matsuura, Y., Seki, H., Saida, K., and Takai, Y. (1991) J. Biol. Chem. 267, 8719-8722 [Abstract/Free Full Text]
  11. Gong, M. C., Iizuka, K., Nixon, G., Browne, J. P., Hall, A., Eccleston, J. F., Sugai, M., Kobayashi, S., Somlyo, A. V., and Somlyo, A. P. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 1340-1345 [Abstract/Free Full Text]
  12. Otto, B., Steusloff, A., Just, I., Aktories, K., and Pfitzer, G. (1996) J. Physiol. (London) 496, 317-329 [Abstract]
  13. Iizuka, K., Ikebe, M., Somlyo, A. V., and Somlyo, A. P. (1994) Cell Calcium 16, 431-445 [CrossRef][Medline] [Order article via Infotrieve]
  14. Leung, T., Manser, E., Tan, E., and Lim, L. (1995) J. Biol. Chem. 270, 29051-29054 [Abstract/Free Full Text]
  15. Matsui, T., Amano, M., Yamamoto, T., Chihara, K., Nakafuku, M., Ito, M., Nakano, T., Okawa, K., Iwamatsu, A., and Kaibuchi, K. (1996) EMBO J. 15, 2208-2216 [Abstract]
  16. Ishizaki, T., Maekawa, M., Fujisawa, K., Okawa, K., Iwamatsu, A., Fujita, A., Watanabe, N., Saito, Y., Kakizuka, A., Morii, N., and Narumiya, S. (1996) EMBO J. 15, 1885-1893 [Abstract]
  17. Amano, M., Ito, M., Kimura, K., Fukata, Y., Chihara, K., Nakano, T., Matsuura, Y., and Kaibuchi, K. (1996) J. Biol. Chem. 271, 20246-20249 [Abstract/Free Full Text]
  18. Kimura, K., Ito, M., Amano, M., Chihara, K., Fukata, Y., Nakafuku, M., Yamamori, B., Feng, J. H., Nakano, T., Okawa, K., Iwamatsu, A., and Kaibuchi, K. (1996) Science 273, 245-248 [Abstract]
  19. Walsh, M. P., Valentine, K. A., Ngai, P. K., Carruthers, C. A., and Hollenberg, M. D. (1984) Biochem. J. 224, 117-127 [Medline] [Order article via Infotrieve]
  20. Laemmli, U. K. (1970) Nature 227, 680-685 [Medline] [Order article via Infotrieve]
  21. Harlow, E., and Lane, D. (1988) Antibodies: A Laboratory Manual, pp. 471-510, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  22. Persechini, A. K., Kamm, K. E., and Stull, J. T. (1986) J. Biol. Chem. 261, 6293-6299 [Abstract/Free Full Text]
  23. Nakagawa, O., Fujisawa, K., Ishizaki, T., Saito, Y., Nakao, K., and Narumiya, S. (1996) FEBS Lett. 392, 189-193 [CrossRef][Medline] [Order article via Infotrieve]
  24. Somlyo, A. P., Kitazawa, T., Himpens, B., Matthijs, G., Horiuti, K., Kobayashi, S., Goldman, Y. E., and Somlyo, A. V. (1989) Adv. Protein Phosphatases 5, 181-195
  25. Gong, M. C., Cohen, P., Kitazawa, T., Ikebe, M., Masuo, M., Somlyo, A. P., and Somlyo, A. V. (1992) J. Biol. Chem. 267, 14662-14668 [Abstract/Free Full Text]
  26. Nakanishi, S., Kakita, S., Takahashi, I., Kawahara, K., Tsukuda, E., Sano, T., Yamada, K., Yoshida, M., Kase, H., Matsuda, Y., Hashimoto, Y., and Nonomura, Y. (1992) J. Biol. Chem. 267, 2157-2163 [Abstract/Free Full Text]
  27. Kitazawa, T., Masuo, M., and Somlyo, A. P. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 9307-9310 [Abstract]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.